Selected
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2359 results found
2012 ∙ Agarwal, N. Ollington, K. Kaneshiro, M. Frenck, R. Melmed, G. Y.
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review
  • All age groups
  • Influenza
  • Pneumococcal disease
  • Meningococcal disease
  • Hepatitis A
  • Hepatitis B
  • Tetanus
  • Pertussis
  • Varicella
  • Herpes zoster
  • Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Pereira, J. A. Quach, S. Heidebrecht, C. L. Quan, S. D. Kolbe, F. Finkelstein, M. Kwong, J. C. Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme, Group
Barriers to the use of reminder/recall interventions for immunizations: a systematic review
  • Healthcare workers
  • United States of America
  • Acceptance
  • Coverage
Rating:
Not applicable
2012 ∙ El-Makhzangy, A. M. Ismail, N. M. Galal, S. B. Sobhy, T. S. Hegazy, A. A.
Can vaccination against pneumococci prevent otitis media with effusion?
  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Bar-On, E. S. Goldberg, E. Hellmann, S. Leibovici, L.
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
  • Newborn
  • Children
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis B
  • Haemophilus influenzae type B
  • Efficacy/effectiveness
  • Safety
  • Administration
Rating:
High
2012 ∙ Ozawa, S. Mirelman, A. Stack, M. L. Walker, D. G. Levine, O. S.
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
  • Low and Middle Income Countries
  • All age groups
  • Economic aspects
Rating:
Not applicable
2012 ∙ Farkouh, R. A. Klok, R. M. Postma, M. J. Roberts, C. S. Strutton, D. R.
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions
  • All age groups
  • Pneumococcal disease
  • Economic aspects
  • Coverage
  • Efficacy/effectiveness
Rating:
Not applicable
2012 ∙ Malagón, T. Drolet, M. Boily, M. C. Franco, E. L. Jit, M. Brisson, J. Brisson, M.
Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Griffiths, U. K. Clark, A. Gessner, B. Miners, A. Sanderson, C. Sedyaningsih, E. R. Mulholland, K. E.
Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta- Analysis of controlled clinical trials
  • Newborn
  • Children
  • Haemophilus influenzae type B
  • Administration
  • Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Kuo, A. M. Brown, J. N. Clinard, V.
Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy
  • All age groups
  • Influenza
  • Safety
Rating:
Critically low
2012 ∙ Manzoli, L. Ioannidis, J. P. Flacco, M. E. De Vito, C. Villari, P.
Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses
  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
Rating:
Not applicable